766 related articles for article (PubMed ID: 23439366)
1. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes.
Koonin EV; Makarova KS
RNA Biol; 2013 May; 10(5):679-86. PubMed ID: 23439366
[TBL] [Abstract][Full Text] [Related]
2. Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes.
Makarova KS; Anantharaman V; Aravind L; Koonin EV
Biol Direct; 2012 Nov; 7():40. PubMed ID: 23151069
[TBL] [Abstract][Full Text] [Related]
3. Viral diversity threshold for adaptive immunity in prokaryotes.
Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
[TBL] [Abstract][Full Text] [Related]
4. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems.
Makarova KS; Aravind L; Wolf YI; Koonin EV
Biol Direct; 2011 Jul; 6():38. PubMed ID: 21756346
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
Faure G; Makarova KS; Koonin EV
J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas systems: beyond adaptive immunity.
Westra ER; Buckling A; Fineran PC
Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
[TBL] [Abstract][Full Text] [Related]
7. Adaptation in CRISPR-Cas Systems.
Sternberg SH; Richter H; Charpentier E; Qimron U
Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
[TBL] [Abstract][Full Text] [Related]
8. Approaches to study CRISPR RNA biogenesis and the key players involved.
Behler J; Hess WR
Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
[TBL] [Abstract][Full Text] [Related]
9. Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR-Cas I-F systems.
Almendros C; Guzmán NM; García-Martínez J; Mojica FJ
Nat Microbiol; 2016 Jun; 1(8):16081. PubMed ID: 27573106
[TBL] [Abstract][Full Text] [Related]
10. Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
van der Oost J; Westra ER; Jackson RN; Wiedenheft B
Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109
[TBL] [Abstract][Full Text] [Related]
11. Origins and evolution of CRISPR-Cas systems.
Koonin EV; Makarova KS
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of CRISPR-Cas Type III prokaryotic defence systems.
Molina R; Sofos N; Montoya G
Curr Opin Struct Biol; 2020 Dec; 65():119-129. PubMed ID: 32712502
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.
Bhaya D; Davison M; Barrangou R
Annu Rev Genet; 2011; 45():273-97. PubMed ID: 22060043
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas Systems in Prokaryotes.
Burmistrz M; Pyrć K
Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527
[TBL] [Abstract][Full Text] [Related]
15. Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis.
Shmakov SA; Makarova KS; Wolf YI; Severinov KV; Koonin EV
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5307-E5316. PubMed ID: 29784811
[TBL] [Abstract][Full Text] [Related]
16. Optimal number of spacers in CRISPR arrays.
Martynov A; Severinov K; Ispolatov I
PLoS Comput Biol; 2017 Dec; 13(12):e1005891. PubMed ID: 29253874
[TBL] [Abstract][Full Text] [Related]
17. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
Liu Q; Zhang H; Huang X
FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria.
Nussenzweig PM; Marraffini LA
Annu Rev Genet; 2020 Nov; 54():93-120. PubMed ID: 32857635
[TBL] [Abstract][Full Text] [Related]
19. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
Newsom S; Parameshwaran HP; Martin L; Rajan R
Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
[TBL] [Abstract][Full Text] [Related]
20. Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids.
Pinilla-Redondo R; Mayo-Muñoz D; Russel J; Garrett RA; Randau L; Sørensen SJ; Shah SA
Nucleic Acids Res; 2020 Feb; 48(4):2000-2012. PubMed ID: 31879772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
